Use of NSAIDs, especially OTC formulations, as well as RAAS blockers and diuretics are risk factors for community-acquired AKI. Use of nonsteroidal anti-inflammatory drugs (NSAIDs), especially ...
Aki India Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 100.66 Crore) operating in Miscellaneous sector. Aki India Ltd. key Products/Revenue Segments include ...